(Total Views: 767)
Posted On: 05/10/2024 3:22:43 PM
Post# of 154122
Something to read over the weekend
https://d1io3yog0oux5.cloudfront.net/_548f7e2...00080X.pdf
Funding
The authors received no specific funding for this work.
CRediT authorship contribution statement
N.B.G. and O.O.Y. supervised the writing of this manuscript by a
medical writer who was funded by CytoDyn. Both authors have accepted responsibility for the content of this manuscript and approved its submission.
Declaration of Competing Interest
OOY serves on the CytoDyn Scientific Advisory Board and is a
scientific consultant (compensated in stock options and cash) for
CytoDyn. OOY is co-founder and board member for CDR3
Therapeutics Corp (stock). OOY is on the Board of Directors for
Applied Medical Inc (stock and cash). NBG serves on the CytoDyn
Scientific Advisory Board with stock option.
https://d1io3yog0oux5.cloudfront.net/_548f7e2...00080X.pdf
Funding
The authors received no specific funding for this work.
CRediT authorship contribution statement
N.B.G. and O.O.Y. supervised the writing of this manuscript by a
medical writer who was funded by CytoDyn. Both authors have accepted responsibility for the content of this manuscript and approved its submission.
Declaration of Competing Interest
OOY serves on the CytoDyn Scientific Advisory Board and is a
scientific consultant (compensated in stock options and cash) for
CytoDyn. OOY is co-founder and board member for CDR3
Therapeutics Corp (stock). OOY is on the Board of Directors for
Applied Medical Inc (stock and cash). NBG serves on the CytoDyn
Scientific Advisory Board with stock option.
(4)
(0)
